Medical Imaging (MEDD) 10-Q 16 Nov 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 09, 2015
Document And Entity Information
Entity Registrant Name	MEDICAL IMAGING CORP.
Entity Central Index Key	1,370,804
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		24,166,481
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,015

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash and Cash Equivalents	$ 159,948	$ 188,206
Accounts Receivable, net	1,235,374	851,884
Prepaid Expenses	46,905	24,165
Total Current Assets	1,442,227	1,064,255
Property and Equipment
Equipment	3,458,377	3,402,671
Less: Accumulated Depreciation	(864,694)	(463,977)
Total Property and Equipment, net	2,593,683	2,938,694
Goodwill	1,977,670	1,977,670
Other Assets
Deposits	11,884	12,463
Loan Receivable	0	1,497
Total Other Assets	11,884	13,960
TOTAL ASSETS	6,025,464	5,994,579
Current Liabilities
Accounts Payable	1,069,240	624,141
Accrued Liabilities	464,163	311,547
Obligations Under Capital Lease, short term portion	212,427	189,923
Promissory Notes, short term portion	427,944	134,999
Royalty Financing, short term portion	102,474	102,219
Convertible Notes, net short term portion	567,055	54,263
Total Current Liabilities	2,843,303	1,417,092
Long Term Liabilities
Obligations Under Capital Lease, long term portion	323,366	459,853
Royalty Financing, long term portion	1,858,204	1,902,698
Convertible Notes, net, long term portion	1,865,092	2,332,708
Total Long Term Liabilities	4,046,662	4,695,259
Total Liabilities	6,889,965	6,112,351
Stockholders' Deficit
Preferred Stock	0	0
Common Stock	24,167	23,947
Additional Paid-In Capital	1,970,223	1,876,484
Accumulated Other Comprehensive Gain	107,077	21,393
Accumulated Deficit	(2,965,968)	(2,039,596)
Total Stockholders' Deficit	(864,501)	(117,772)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 6,025,464	$ 5,994,579

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value in dollars	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value in dollars	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	24,166,481	23,946,481
Common stock, shares outstanding	24,166,481	23,946,481

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenue:
Sales	$ 1,675,399	$ 1,275,341	$ 5,500,217	$ 3,787,403
Less: Cost of Sales	937,795	711,346	2,865,499	2,212,967
Gross Margin	737,604	563,995	2,634,718	1,574,436
Operating Expenses:
Labor	318,167	221,148	957,660	597,412
General and Administrative	172,640	94,332	525,065	202,829
Depreciation	137,116	50,252	409,854	129,907
Rent Office Space and Servers	128,211	39,534	393,663	113,256
Legal and Professional	82,985	40,322	305,180	138,400
Insurance	20,766	10,724	69,928	33,832
Travel	10,091	4,697	31,202	31,167
Advertising	5,833	8,290	23,415	42,543
Management Fees	5,100	4,778	28,513	13,866
Amortization	0	0	0	22,925
Bad Debt Expense (Recapture)	(849)	(515)	5,530	14,465
Total Operating Expenses	880,060	473,562	2,750,010	1,340,602
Income (Loss) from Operations	(142,456)	90,433	(115,292)	233,834
Other Income and (Expenses):
Other Income	7,326	512	15,971	715
Foreign Currency Gains (Losses)	14,046	145	(3,473)	954
Interest, Discount of Debt & Penalties Expenses	(404,435)	(112,323)	(867,542)	(306,011)
Total Other Income (Expenses)	(383,063)	(111,666)	(855,044)	(304,342)
Loss Before Provision for Income Taxes	(525,519)	(21,233)	(970,336)	(70,508)
Provision for Income (Taxes) Credit	(1,092)	5,122	43,964	5,122
Net Loss	(526,611)	(16,111)	(926,372)	(65,386)
Comprehensive Income (Loss)	28,633	334	85,684	63
Total Comprehensive Income (Loss)	$ (497,978)	$ (15,777)	$ (840,688)	$ (65,323)
Basic and Diluted Loss per Share	$ (0.021)	$ (0.001)	$ (0.035)	$ (0.003)
Weighted Average Shares Outstanding - Basic and Diluted	24,166,481	23,850,828	24,143,183	23,688,366

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (926,372)	$ (65,386)
Adjustments to Reconcile Net Loss to Net Cash provided by Operating Activities:
Depreciation	409,854	129,907
Asset Write Off	0	961
Accrued Interest Converted into note	0	209,078
Amortization of Debt Discount	463,383	66,283
Stock-Based Compensation	92,919	150
Amortization of Intangible Assets	0	22,925
Foreign Currency Transaction Loss	579	498
Changes in Operating Assets and Liabilities:
Accounts Receivable	(383,490)	(148,193)
Prepaid Expenses	(22,740)	(29,131)
Loans Receivable	1,497	260
Accounts Payable and accrued liabilities	597,715	115,400
NET CASH AND CASH EQUIVALENTS PROVIDED BY OPERATING ACTIVITIES	233,345	302,752
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments on acquisition liability	0	(110,063)
Deposit on possible acquisition	0	(20,000)
Equipment Purchase	(45,633)	(372,719)
NET CASH USED IN INVESTING ACTIVITIES	(45,633)	(502,782)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Promissory Notes	1,171,137	0
Proceeds from Convertible Debt	20,000	445,000
Royalty Fee Payment	(310,348)	0
Principal Payment on Convertible Debt	(45,000)	(230,255)
Principal Payments on Promissory Notes	(1,004,420)	(26,483)
Principal Payments on Capital Lease Obligations	(133,023)	8,720
NET CASH AND CASH EQUIVALENTS USED BY IN FINANCING ACTIVITIES	(301,654)	196,982
Gain (Loss) due to foreign currency translation	85,684	63
NET CHANGE IN CASH AND CASH EQUIVALENTS	(28,258)	(2,985)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	188,206	77,300
CASH AND CASH EQUIVALENTS AT END OF PERIOD	159,948	74,315
Cash paid during the year for:
Interest	261,838	30,650
Income Taxes	29,295	54,864
Non-cash financing and investing activities:
Shares Issued for Convertible Note	1,040	37,155
Acquisition Liability Assigned to Loan Payable	0	64,937
Acquisition Liability Assigned to Promissory Note	0	25,000
Equipment purchase under capital lease	18,997	0
Accrued Interest converted to Note	$ 75,039	$ 0

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Summary of Significant Accounting Policies	Note 1. Organization and Summary of Significant Accounting Policies Organization and Basis of Presentation Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent diagnostic imaging facility located in Pottsville, Pennsylvania. In 2014, the company purchased Partners Imaging Center of Venice, LLC (“PIV”) located in Venice, Florida; Partners Imaging Center of Naples, LLC (“PIN”) located in Naples, Florida; and Partners Imaging Center of Charlotte, LLC (“PIC”) located in Port Charlotte, Florida. Basis of Presentation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31. Principle of Consolidation The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, CTS, SMI, PIV, PIN, and PIC. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’, SMI’s, PIV’s, PIN’s, and PIC’s accumulated earnings prior to their acquisitions (March 2, 2009, December 10, 2012, and November 1, 2014, respectively) are not included in the consolidated balance sheet. Use of Estimates and Assumptions The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At September 30, 2015, and December 31, 2014, cash includes cash on hand and cash in the bank. Accounts Receivable Credit Risk The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio. Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables. As of September 30, 2015 and December 31, 2014, the allowance for bad debts was $70,203 and $64,673, respectively. Bad debt recapture for the three months ended September 30, 2015 and 2014 was $849 and $515, respectively. Bad debt expense for the nine months ended September 30, 2015 and 2014 was $5,530 and $14,465, respectively. As of September 30, 2015 two customers of CTS totalled approximately 9% of the total accounts receivable. As of December 31, 2014, three customers totalled approximately 16% of the total accounts receivable. Goodwill and Indefinite Intangible Assets The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets Revenue Recognition The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the nine months ended September 30, 2015, CTS held six contracts; four contracts that are renewable on a year-to-year basis, two contracts that are renewable in 2016, and 2018. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy). Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, Revenue Recognition – Principal Agent Considerations For SMI, PIV, PIN, and PIC revenue is recognized on the date of service, and recorded on an aggregate monthly basis. Cost of Sales Cost of sales includes fees paid to radiologists for reading services, transcription fees, equipment repairs, system license and usage costs. Impairment of Long-Lived Assets In accordance with ASC Topic 360, Property, Plant and Equipment, Amortization and Depreciation Depreciation and amortization are calculated using the straight-line method over the following useful lives: 3 - 7 years Equipment 5 – 7 years Furniture and Fixtures 3 - 5 years Non-compete Contract 39 years Leasehold Improvements Stock Based Compensation The Company follows ASC 718, stock compensation; a fair calculation is performed by the Company to establish the "grant date fair value" of each award which will also be the amount recorded by the Company as stock based compensation expense pursuant to the guidance set forth in ASC 718 to produce an estimated fair value. The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the binomial option pricing model (“BOPM”). The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate. The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the BOPM on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received. The Company did not recognized stock-based compensation expenses from stock options to non-employees for the three months ended September 30, 2015 and 2014. The Company recognized stock-based compensation expenses of $34,683 and $0 from stock options granted to non-employees for the nine months ended September 30, 2015 and 2014. The stock based compensation for the nine months ended September 30, 2015 pertains to stock options granted to non-employees. The options were valued using the BOPM and included in the Legal and professional operating expenses in the consolidated statements of operations. The Company recognized stock-based compensation expenses of $0 from stock and stock options granted to employees for the three months ended September 30, 2015, and 2014, respectively. The Company recognized stock-based compensation expenses of $58,236, and $150 from stock and stock options granted to employees for the nine months ended September 30, 2015, and 2014, respectively. The stock based compensation for the nine months ended September 30, 2015 includes stock options granted to employees of $47,896. The options were valued using the BOPM and included in the labor and management fees operating expenses in the consolidated statements of operations for $34,683, and $13,213, respectively. Fair Value of Financial Instruments The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation. The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities. Fair Value Measurements The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments. The company does not have assets and liabilities that are carried at fair value on a recurring basis. Foreign Currency Translation The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity. The Company recognized a foreign currency gain on transactions from operations of $14,046 and foreign currency gain of $145 for the three months ended September 30, 2015 and 2014, respectively. The Company recognized a foreign currency loss on transactions from operations of $3,473 and foreign currency gain of $954 for the nine months ended September 30, 2015 and 2014, respectively. The Company recognized total comprehensive income of $28,633 and $334 for the three months ended September 30, 2015 and 2014, respectively. The Company recognized total comprehensive income of $85,684 and $63 for the nine months ended September 30, 2015 and 2014, respectively. Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Net Income (Loss) Per Share The Company follows the provisions of ASC Topic 260, Earnings per Share Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive. The information related to basic and diluted earnings per share is as follows: Three Months Ended Nine Months Ended September 30, 2015 September 30, 2014 September 30, 2015 September 30, 2014 Numerator: Continuing operations: Total Comprehensive Loss $ (497,978) $ (15,777) $ (840,688) $ (65,323) Total $ (497,978) $ (15,777) $ (840,688) $ (65,323) Total Comprehensive Loss $ (497,978) $ (15,777) $ (840,688) $ (65,323) Denominator: Weighted average number of shares outstanding – basic and diluted 24,166,481 23,850,828 24,143,183 23,688,366 EPS: Basic: Total Comprehensive Loss $ (0.021) $ (0.001) $ (0.035) $ (0.003) Net Loss $ (0.021) $ (0.001) $ (0.035) $ (0.003) Diluted Total Comprehensive Loss $ (0.021) $ (0.001) $ (0.035) $ (0.003) Total Comprehensive Loss $ (0.021) $ (0.001) $ (0.035) $ (0.003) Recent Accounting Updates The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Interim Financial Statements

Interim Financial Statements	9 Months Ended
	Sep. 30, 2015
Quarterly Financial Information Disclosure [Abstract]
Interim Financial Statements	Note 2. Interim Financial Statements The accompanying interim unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month period ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2015
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 3. Property and Equipment For the nine months ended, September 30, 2015, the Company has acquired additional computer equipment of $30,834 for its CTS subsidiary and additional medical imaging equipment hardware of $33,796 for its PIV subsidiary. Property and equipment are stated at cost. Depreciation is calculated using the straight - line method over the estimated useful life of the assets. At September 30, 2015 and December 31, 2014, the major class of property and equipment were as follows: September 30, 2015 December 31, 2014 Estimated useful lives Computer/Office Equipment $ 457,776 $ 435,867 3-7 years Medical Equipment 2,156,820 2,123,023 3-7 years Leasehold Improvements 843,781 843,781 39 years Less: Accumulated Depreciation (864,694) (463,977) Net Book Value $ 2,593,683 $ 2,938,694 Depreciation expense was $137,116 and $50,252 for the three months ended September 30, 2015 and 2014, respectively. Depreciation expense was $409,854 and $129,907 for the nine months ended September 30, 2015 and 2014, respectively.

Business Combination

Business Combination	9 Months Ended
	Sep. 30, 2015
Business Combinations [Abstract]
Business Combination	Note 4. Business Combination On October 31, 2014, the Company acquired 100% of the shares of three separate entities, Partners Imaging Center of Venice, LLC, Partners Imaging Center of Naples, LLC, and Partners Imaging Center of Charlotte, LLC., for an aggregate cash consideration described in detail below. Each company was purchased for its medical equipment, general office fixtures, Medicare number and facility lease. There were no prior earnings, accounts receivable, accounts payable, or other assets or liabilities acquired in any of the acquisitions. Medical imaging services began to be offered on November 1, 2014 by PIV, PIN, and PIC. The Company paid an aggregate purchase price of $1,800,000 as follows (at fair value): Total PIV PIN PIC Cash $ 1,800,000 959,286 533,571 307,143 Total consideration paid $ 1,800,000 959,286 533,571 307,143 The following assets and liabilities were recognized (at fair value): Total PIV PIN PIC Fixed Assets $ 1,245,000 695,000 375,000 175,000 Goodwill 555,000 264,286 158,571 132,143 Net assets purchased $ 1,800,000 959,286 533,571 307,143 The Company has evaluated the transactions and believes that the historical cost of the tangible and intangible assets acquired approximated the fair market value given the current nature of the assets acquired. As part of the acquisitions, the Company has acquired aggregate Goodwill of $555,000. The Company expects to amortize the full amounts of goodwill for tax purposes. The Company will perform annual testing of goodwill for impairment. The amounts of revenue and gross earnings included in the consolidated income statement for the nine months ended September 30, 2015 and 2014 are as follow: Nine Months Ended September 30, 2015 Total PIV PIN PIC Revenue $ 2,282,359 1,064,262 555,754 662,343 Gross Margin $ 1,329,854 591,889 328,564 409,401 Nine Months Ended September 30, 2014 Total PIV PIN PIC Revenue $ - - - - Gross Margin $ - - - - Costs related to the acquisitions, which include legal fees, in the aggregate amount of about $29,500 have been charged directly to operations and are included in legal and professional expenses in the 2014 consolidated income statement.

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 5. Goodwill The change in the carrying amount of goodwill for the two years ended September 30, 2015 was: Balance as of January 1, 2014 $ 1,422,670 Acquisition of goodwill during the year 555,000 Changes in goodwill during the year - Balance as of December 31, 2014 1,977,670 Changes in goodwill during the year - Balance as of September 30, 2015 $ 1,977,670

Lease Commitments

Lease Commitments	9 Months Ended
	Sep. 30, 2015
Leases, Operating [Abstract]
Lease Commitments	Note 6. Lease Commitments CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $3,550 in utilities, realty taxes, and operating costs, for a total of approximately $6,000 per month. The Lease renewed in April 2013 for a period of five years and will expire in March 2018. On renewal, CTS was given a rental credit of approximately $28,000. This lease was accounted for as an operating lease. SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. Monthly rental amounts in 2014 were $5,437 per month plus approximately $1,674 in utilities, realty taxes, and operating costs. SMI has a lease for office space in Dallas, Texas of approximately $880 per month. The lease will expire in August 31, 2016. PIV has a lease for office space in Venice, Florida. The lease will expire October 1, 2016. Monthly rental amounts are $15,377 per month. PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020. Monthly rental amounts are $9,543 per month. PIC has a lease for office space in Port Charlotte, Florida. The lease will expire June 20, 2016. Monthly rental amounts are $5,512 per month. Expected Lease commitments for the next three years: Year Office Space Servers Total 2015 $ 133,269 $ 4,500 $ 137,769 2016 423,943 18,000 441,943 2017 186,516 6,000 192,516 $ 743,727 $ 28,500 $ 772,227

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	9 Months Ended
	Sep. 30, 2015
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Note 7. Accounts Payable and Accrued Liabilities As of September 30, 2015 and December 31, 2014, the trade payables and accrued liabilities of the Company were $1,533,403 and $935,688, respectively. Of the total amount as of September 30, 2015, $1,069,240 was related to ongoing operations representing a balance owing to trade payables. $288,502 was related to accrued payroll and withholdings liabilities, and $175,661 was related to Federal and State income tax owing. Of the total amount as of December 31, 2014, $624,141 was related to ongoing operations representing a balance owing to trade payables. $73,461 was related to accrued payroll and withholdings liabilities, and $238,086 was related to Federal and State income tax owing.

Obligations Under Capital Lease

Obligations Under Capital Lease	9 Months Ended
	Sep. 30, 2015
Leases, Capital [Abstract]
Obligations Under Capital Lease	Note 8. Obligations Under Capital Lease SMI MRI Machines Capital Lease: On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000. The gross amount of the equipment held under capital leases totals $555,000 ($240,583 net book value after accumulated amortization of $314,417) at September 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $27,750 for the three months ended September 30, 2015 and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $83,250 for the nine months ended September 30, 2015 and 2014, respectively. SMI X-ray Machine Capital Lease: On July 03, 2014, Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $78,250. The gross amount of the x-ray machine held under the capital lease is $78,250 ($58,688 net book value after accumulated amortization of $19,562) at September 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $3,913 for the three months ended September 30, 2015 and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $11,738, and $3,913 for the nine months ended September 30, 2015 and 2014, respectively. SMI PACS/RIS System Capital Lease: On August 19, 2014, the Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $3,115, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the system for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $162,333. The gross amount of the PACS/RIS system held under the capital lease is $162,333 ($116,133 net book value after accumulated amortization of $46,200) at September 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $8,117, and $4,058 for the three months ended September 30, 2015, and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $24,350, and $4,058 for the nine months ended September 30, 2015, and 2014, respectively. PV, PN, PC PACS/RIS Capital Lease: On November 26, 2014, the Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, PIV, is to make monthly payments of $3,094, plus applicable sales tax, over a period of 60 months. At the end of the lease, PIV will have the option to purchase the system for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $167,107. The gross amount of the PACS/RIS system held under the capital lease is $167,107 ($140,648 net book value after accumulated amortization of $26,459) at September 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $8,355, and $0 for the three months ended September 30, 2015, and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $25,065, and $0 for the nine months ended September 30, 2015, and 2014, respectively. PV, PN, PC Computers Capital Lease: On December 10, 2014, the Company has entered into a capital lease agreement to lease computers that were delivered and installed in December 2014. Under the terms of the lease, the Company is to make monthly payments of $813.16, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $25,108. The gross amount of the computers held under the capital lease is $25,108 ($20,575 net book value after accumulated amortization of $6,625) at September 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $2,092, and $0 for the three months ended September 30, 2015, and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $6,277, and $0 for the nine months ended September 30, 2015, and 2014, respectively. CTS Computers Lease On January 21, 2015, the Company has entered into a capital lease agreement to lease computers that were installed on the same date of acceptance. Under the terms of the lease, the company is to make monthly payments of $546, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $18,997 (amount is carried in Canadian dollar). The gross amount of the computers held under the capital lease is $18,997 ($14,776 net book value after accumulated amortization of $4,221) at September 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $1,683, and $0 for the three months ended September 30, 2015, and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $4,488, and $0 for the nine months ended September 30, 2015, and 2014, respectively. Minimum future lease payments under the capital leases as of September 30, 2015 are as follow: Minimum Lease Payments Total SMI MRI SMI PACS/RIS Lease SMI Xray Lease PV,PN, PC PACS/RIS Lease PV,PN,PC Computers Lease CTS Computers Lease 2015 $ 60,255 33,038 9,345 4,486 9,308 2,439 1,639 2016 240,916 132,152 37,380 17,944 37,128 9,758 6,554 2017 107,951 - 37,380 17,944 37,128 8,945 6,554 2018 93,545 - 37,380 17,944 37,128 - 1,092 2019 83,356 - 34,265 11,963 37,128 - - 2020 3,094 - - - 3,094 - - Total minimum lease payments 589,118 165,190 155,750 70,282 160,914 21,142 15,840 Less amount representing interest 53,342 11,027 17,377 8,168 14,082 2,250 437 Present value of minimum lease payments 535,776 154,163 138,373 62,114 146,832 18,892 15,403 Less current portion of minimum lease payments 212,427 121,695 30,288 14,432 31,541 8,199 6,272 Long-term capital lease obligations $ 323,349 32,468 108,085 47,682 115,291 10,693 9,131

Convertible Notes

Convertible Notes	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Convertible Notes	Note 9. Convertible Notes Series B: On December 3, 2012, the Company sold, through a private placement to accredited investors, three year 12% convertible notes (“Series B Notes”) in the aggregate principal amount of $1,865,000. On March 27, 2013, the Company sold an additional $150,000 of Series B Notes. Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month. The Notes are convertible into common shares of the Company at $0.10 per share. In addition, each holder of Series B Notes received shares dependent on the dollar amount of Notes purchased. The total number of shares issued was 5,315,000 shares of common stock of the Company. $1,865,000 of Series B Notes issued on December 3, 2012 mature on July 1, 2018; and $150,000 of Series B Notes issued March 27, 2013 mature on March 31, 2016. For the nine months ended September 30, 2015, $181,350 of accrued interest was recorded on the notes and paid. In accordance with ASC 470, Debt with conversion and other options, on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $244,275. Amortization of the discount for the nine months ended September 30, 2015 was $61,068. The Details of Series B Notes are as follows: Issuance December 31, December 31, Nine Months Nine Months Nine Months September 30, Maturity Date 2014 2014 Ended Ended Ended 2015 Date Balance Unamortized September 30, September 30, September 30, Balance, net Discount 2015 2015 2015 Beginning Interest (Payments) Amortization Balance Accrued of Debt Discount 03-Dec-12 $ 25,000 $ (344) $ 2,250 $ (2,250) $ 281 $ 24,937 31-Dec-15 03-Dec-12 125,000 (5,594) 11,250 (11,250) 3,731 123,137 31-Dec-15 03-Dec-12 50,000 (1,031) 4,500 (4,500) 844 49,813 31-Dec-15 03-Dec-12 25,000 (344) 2,250 (2,250) 281 24,937 31-Dec-15 03-Dec-12 25,000 (344) 2,250 (2,250) 281 24,937 31-Dec-15 03-Dec-12 25,000 (344) 2,250 (2,250) 281 24,937 31-Dec-15 03-Dec-12 1,500,000 (61,875) 135,000 (135,000) 50,625 1,488,750 01-Jul-18 03-Dec-12 50,000 (1,031) 4,500 (4,500) 844 49,813 31-Dec-15 03-Dec-12 15,000 (206) 1,350 (1,350) 169 14,963 31-Dec-15 03-Dec-12 100,000 (3,656) 9,000 (9,000) 2,569 98,913 31-Dec-15 27-Mar-13 25,000 (646) 2,250 (2,250) 388 24,742 31-Mar-16 27-Mar-13 25,000 (646) 2,250 (2,250) 388 24,742 31-Mar-16 27-Mar-13 25,000 (646) 2,250 (2,250) 388 24,742 31-Mar-16 Total $ 2,015,000 $ (76,706) $ 181,350 $ (181,350) $ 61,068 $ 1,999,362 Following are maturities of the long –term debt in Series B Notes: Principal Payments Interest Payments Amortization of Discount 2015 $ 365,000 $ 60,450 $ 14,088 2016 150,000 184,500 1,550 2017 - 180,000 - 2018 1,500,000 90,000 Total $ 2,015,000 $ 514,950 $ 15,638 Series C: On May 22, 2014, the Company sold, through private placement to accredited investors, three year 12% convertible notes (“Series C Notes”) in the aggregate principal amount of $95,000. The Notes bear interest at a rate of 12% per annum, payable to the holder at1% per month, with the principal amount due on May 31, 2017. The Notes are convertible into shares of the Company’s common stock at an initial conversion rate of $0.15 per share. In addition, each holder of Series C Notes received shares dependent on the dollar amount of Notes purchased. On August 25, 2014, October 31, 2014 and February 17, 2015, the Company sold an additional $75,000, $50,000 and $20,000, respectively of “series C notes”. The total number of shares issued was 240,000 shares of common stock of the Company. In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $12,695. Amortization of the discount for the nine months ended September 30, 2015 was $3,772. For the nine months ended September 30, 2015, $21,200 in accrued interest was recorded on the notes and paid. Issuance December 31, Unamortized Nine Months Nine Months Nine Months Nine Months September 30, Maturity Date 2014 Discount Ended Ended Ended Ended 2015 Date Balance Beginning September 30, September 30, September 30, September 30, Balance, net Balance 2015 2015 2015 2015 Proceeds Interest (Payments) Amortization Accrued of Debt Discount 22-May-14 $ 50,000 $ (2,417) $ - $ 4,500 $ (4,500) $ 750 $ 48,333 31-May-17 22-May-14 22,500 (1,088) - 2,025 (2,025) 338 21,750 31-May-17 22-May-14 22,500 (1,088) - 2,025 (2,025) 338 21,750 31-May-17 25-Aug-14 50,000 (3,419) - 4,500 (4,500) 993 47,574 31-October-17 25-Aug-14 25,000 (1,709) - 2,250 (2,250) 496 23,787 31-October-17 31-Oct-14 50,000 (2,479) - 4,500 (4,500) 656 48,177 31-October-17 17-Feb-15 - (1,040) 20,000 1,400 (1,400) 202 19,162 17-February-18 Total $ 220,000 $ (13,240) $ 20,000 $ 21,200 $ (21,200) $ 3,772 $ 230,532 Following are maturities of the long –term debt in Series C Notes: Principal Payments Interest Payments Amortization of Discount 2015 $ - $ 7,200 $ 1,105 2016 - 24,400 4,876 2017 220,000 12,650 3,429 2018 20,000 400 58 Total $ 240,000 $ 44,650 $ 9,468 Individually issued Convertible Note: On March 26, 2014, the Company issued a $300,000 convertible note to a non-affiliate. The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. In addition to interest payments the Company will be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for three years until the note due date of February 27, 2017. The note is convertible into common shares of the Company at $0.15 per share. In addition, the non-affiliate will receive 300,000 shares as part of the note agreement. For the nine months ended September 30, 2015, $21,533 of accrued interest was recorded on the notes and paid. In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $25,500. Amortization of the discount for the nine months ended September 30, 2015 was $6,375. Summary of the note is as follows: September 30, 2015 December 31, 2014 Convertible note Beginning Balance $ 260,000 $ 300,000 Less: unamortized debt discount (12,750) (19,125) Convertible notes principal, net 247,250 280,875 Less: Payments in Period (66,533) (66,504) Added: Accrued interest 21,533 26,504 Total Convertible note, net $ 202,250 $ 240,875 Less: short term portion, net 56,442 54,263 Long term portion, net $ 145,808 $ 186,612 Following are maturity of the individually issued convertible note for each of the next 5 years: Principal Payments Interest Payments Amortization of Discount 2015 $ 15,000 $ 6,352 $ 2,125 2016 60,000 20,748 8,500 2017 140,000 2,625 2,125 Total $ 215,000 $ 29,725 $ 12,750

Promissory Notes

Promissory Notes	9 Months Ended
	Sep. 30, 2015
Other Liabilities Disclosure [Abstract]
Promissory Notes	Note 10. Promissory Notes In June 2014, $64,937 of the SMI acquisition liability that was due as part of SMI acquisition was assigned to a promissory note accruing interest at an annual rate of 12%, and due on February 1, 2015. Interest accrued is to be paid out monthly with the principal amount due on maturity. The note has been fully paid in February 2015. In December 2014, the Company issued a short term loan payable to a non-related party for $50,000 in proceeds. The note is due on demand and does not accrue interest. For the nine months ended September 30, 2015, the Company made payments of $54,000 towards the balance and has received additional proceeds of $4,000. As of September 30, 2015, the loan is paid out in full. For the nine months ended September 30, 2015, the Company has issued loans total of $720,000, the loans terms call for weekly payments of $28,000 towards the principal balance and interest. The final payment was due August 18, 2015. For the nine months ended September 30, 2015, the Company issues loans total of $429,000, the loans call for weekly payments of $13,000 towards the principal balance and interest. The final payment is due April 5, 2016. In June 2015, the Company has issued a loan of $120,700, the loan terms call for a daily payment of $453, towards the principal balance and interest. The final payment is due July 7, 2016. In June 2015 the company has issued a loan of $163,362, the loan terms call for a daily payment of $613, towards the principal balance and interest. The final payment is due July 7, 2016. Amounts are carried in Canadian Dollars. A summary of the promissory notes is as follows: Promissory notes at January 1, 2014 $ 45,015 Added: Note assigned through December 31, 2014 64,937 Added: Accrued Interest through December 31, 2014 6,069 Added: Proceeds through December 31, 2014 50,000 Less: Payments through December 31, 2014 (31,022) Promissory notes at December 31, 2014 $ 134,999 Added: Accrued Interest through September 30, 2015 2,000 Added: Proceeds through September 30, 2015 1,425,835 Less: Payments through September 30, 2015 (1,004,973) Added: Discount through September 30, 2015 (129,917) Promissory notes at September 30, 2015 $ 427,944 Less: Short term portion 427,944 Long term portion September 30, 2015 $ -

Royalty Financing

Royalty Financing	9 Months Ended
	Sep. 30, 2015
Royalty Financing
Royalty Financing	Note 11. Royalty Financing On October 31, 2014, the Company entered into a royalty purchase agreement with Grenville Strategic Royalty Corp. for the amount of $2,000,000. The agreement calls for a monthly payment to the seller based on a percentage of the total of certain revenue items and subject to a minimum payment amount. For the nine months ended September 30, 2015, the Company paid a total of $346,378 in royalty payments. The amount financed is recorded net of discount to be amortized of the term. As of September 30, 2015 the Company has recorded discount amortization expense of $307,056. The balance as shown on the consolidated balance sheet as of September 30, 2015 is $1,960,679.

Major Customers

Major Customers	9 Months Ended
	Sep. 30, 2015
Major Customers
Major Customers	Note 12. Major Customers For the nine months ending September 30, 2015 and 2014, revenue was derived primarily from radiology services. Major customers representing more than 10% of total revenue for the nine months ended September 30, 2015 and 2014 are as follow: Nine Months Ended Nine Months Ended September 30, 2015 September 30, 2014 Customers Revenue amount Revenue percentage Revenue amount Revenue percentage Contract A $ - 0% $ 650,079 17% Contract E 436,666 12% 698,618 18% Contract F 262,019 7% 430,57 11% There were no closing balances for accounts receivable greater than 10% of total balance.

Major Vendors

Major Vendors	9 Months Ended
	Sep. 30, 2015
Major Vendors
Major Vendors	Note 13. Major Vendors There were no major vendors for the nine months ended September 30, 2015.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions	Note 14. Related Party Transactions During January 2015, the Company entered into an agreement with a company that is owned and controlled by a major shareholder, to provide consulting services. Fees payable for performance of the consulting services are $10,000 per month. In addition to the monthly fees, the consultant was paid at signing of the agreement, four million two hundred thousand (4,200,000) options to purchase common stock of the client at an exercise price of $0.15 per share with an expiry date of December 31, 2019; details of the options recognition is disclosed in Note 15. Fees paid to the related party consultant are included as an expense in Legal and Professional fees in the accompanying statement of operations for the period. At September 30, 2015, the Company had $0 balance owing for services rendered.

Common Stock Transactions

Common Stock Transactions	9 Months Ended
	Sep. 30, 2015
Equity [Abstract]
Common Stock Transactions	Note 15. Common Stock Transactions On January 27, 2015, the Company granted options as considerations for services provided by the CEO of the company. The options are to purchase up to 4,200,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $34,683. On January 27, 2015, the Company granted options as considerations for consulting services provided to the company. The options are to purchase up to 4,200,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $34,683. On January 27, 2015, the Company granted options as considerations for services provided by the CFO of the Company. The options are to purchase up to 1,600,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $13,213. For the nine months ended September 30, 2015, 200,000 shares were issued for services valued at $10,340 based upon the closing price of the Company’s common stock at the grant date. For the nine months ended September 30, 2015, 20,000 shares were issued as part of series C convertible note agreements. The shares were valued at $1,040 based upon the closing price of the Company’s common stock at the grant date. For the year ended December 31, 2014, 5,000 shares were issued for services valued at $150 based upon the closing price of the Company’s common stock at the grant date. For the year ended December 31, 2014, 300,000 shares were issued as part of individually issued convertible note agreements. The shares were valued at $25,500 based upon the closing price of the Company’s common stock at the grant date. For the year ended December 31, 2014, 220,000 shares were issued as part of series C convertible note agreements. The shares were valued at $14,280 based upon the closing price of the Company’s common stock at the grant date.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Note 16. Income Tax The Company follows ASC 740, Income Taxes The provisions of ASC 740 require companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure. Management does not believe that the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2015
Going Concern
Going Concern	Note. 17. Going Concern As shown in the accompanying consolidated financial statements, the Company incurred net loss of $926,372 for the nine months ended September 30, 2015 as well as a working capital deficit of $1,401,076. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Management plans to raise additional financing in order to continue its operations and fulfill its debt obligations in 2015, but there can be no assurances that the plan will be successful. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 18. Subsequent events Subsequent to quarter end, a non-related party holder of $1,500,000 of series B convertible has agreed to extend the maturity date to July 1, 2017. As consideration for this extension, the company will issue to the holder a warrant to purchase 1,500,000 shares of common stock of the company at an exercise price of $0.07 per share, which warrant will be exercisable from November 16, 2015 to and including July 1, 2018. The Company evaluated subsequent events through the date the consolidated financial statements were issued.

Accounting Policies (Policies)

Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Organization and Basis of Presentation	Organization and Basis of Presentation Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent diagnostic imaging facility located in Pottsville, Pennsylvania. In 2014, the company purchased Partners Imaging Center of Venice, LLC (“PIV”) located in Venice, Florida; Partners Imaging Center of Naples, LLC (“PIN”) located in Naples, Florida; and Partners Imaging Center of Charlotte, LLC (“PIC”) located in Port Charlotte, Florida. Basis of Presentation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Principle of Consolidation	Principle of Consolidation The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, CTS, SMI, PIV, PIN, and PIC. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’, SMI’s, PIV’s, PIN’s, and PIC’s accumulated earnings prior to their acquisitions (March 2, 2009, December 10, 2012, and November 1, 2014, respectively) are not included in the consolidated balance sheet.
Use of Estimates and Assumptions	Use of Estimates and Assumptions The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At September 30, 2015, and December 31, 2014, cash includes cash on hand and cash in the bank.
Accounts Receivable Credit Risk	Accounts Receivable Credit Risk The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio. Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables
Goodwill and Indefinite Intangible Assets	Goodwill and Indefinite Intangible Assets The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets
Revenue Recognition	Revenue Recognition The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the nine months ended September 30, 2015, CTS held six contracts; four contracts that are renewable on a year-to-year basis, two contracts that are renewable in 2016, and 2018. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy). Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, Revenue Recognition – Principal Agent Considerations For SMI, PIV, PIN, and PIC revenue is recognized on the date of service, and recorded on an aggregate monthly basis.
Cost of Sales	Cost of Sales Cost of sales includes fees paid to radiologists for reading services, transcription fees, equipment repairs, system license and usage costs.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets In accordance with ASC Topic 360, Property, Plant and Equipment,
Amortization and Depreciation	Amortization and Depreciation Depreciation and amortization are calculated using the straight-line method over the following useful lives
Stock Based Compensation	Stock Based Compensation The Company follows ASC 718, stock compensation; a fair calculation is performed by the Company to establish the "grant date fair value" of each award which will also be the amount recorded by the Company as stock based compensation expense pursuant to the guidance set forth in ASC 718 to produce an estimated fair value. The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the binomial option pricing model (“BOPM”). The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate. The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the BOPM on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation. The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
Fair Value Measurements	Fair Value Measurements The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments. The company does not have assets and liabilities that are carried at fair value on a recurring basis.
Foreign Currency Translation	Foreign Currency Translation The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes
Net Income (Loss) Per Share	Net Income (Loss) Per Share The Company follows the provisions of ASC Topic 260, Earnings per Share Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive.
Recent Accounting Updates	Recent Accounting Updates The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Organization and Summary of S25

Organization and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Earnings Per Share	Three Months Ended Nine Months Ended September 30, 2015 September 30, 2014 September 30, 2015 September 30, 2014 Numerator: Continuing operations: Total Comprehensive Loss $ (497,978) $ (15,777) $ (840,688) $ (65,323) Total $ (497,978) $ (15,777) $ (840,688) $ (65,323) Total Comprehensive Loss $ (497,978) $ (15,777) $ (840,688) $ (65,323) Denominator: Weighted average number of shares outstanding – basic and diluted 24,166,481 23,850,828 24,143,183 23,688,366 EPS: Basic: Total Comprehensive Loss $ (0.021) $ (0.001) $ (0.035) $ (0.003) Net Loss $ (0.021) $ (0.001) $ (0.035) $ (0.003) Diluted Total Comprehensive Loss $ (0.021) $ (0.001) $ (0.035) $ (0.003) Total Comprehensive Loss $ (0.021) $ (0.001) $ (0.035) $ (0.003)

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2015
Property, Plant and Equipment [Abstract]
Property Plant and Equipment	September 30, 2015 December 31, 2014 Estimated useful lives Computer/Office Equipment $ 457,776 $ 435,867 3-7 years Medical Equipment 2,156,820 2,123,023 3-7 years Leasehold Improvements 843,781 843,781 39 years Less: Accumulated Depreciation (864,694) (463,977) Net Book Value $ 2,593,683 $ 2,938,694

Business Combination (Tables)

Business Combination (Tables)	9 Months Ended
	Sep. 30, 2015
Business Combinations [Abstract]
Schedule of Purchase Price Allocation	Total PIV PIN PIC Cash $ 1,800,000 959,286 533,571 307,143 Total consideration paid $ 1,800,000 959,286 533,571 307,143
Schedule of Recognized Assets Acquired and Liabilities Assumed	Total PIV PIN PIC Fixed Assets $ 1,245,000 695,000 375,000 175,000 Goodwill 555,000 264,286 158,571 132,143 Net assets purchased $ 1,800,000 959,286 533,571 307,143
Schedule of Revenue and Gross Earnings from Acquired Assets	Nine Months Ended September 30, 2015 Total PIV PIN PIC Revenue $ 2,282,359 1,064,262 555,754 662,343 Gross Margin $ 1,329,854 591,889 328,564 409,401 Nine Months Ended September 30, 2014 Total PIV PIN PIC Revenue $ - - - - Gross Margin $ - - - -

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Sep. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Balance as of January 1, 2014 $ 1,422,670 Acquisition of goodwill during the year 555,000 Changes in goodwill during the year - Balance as of December 31, 2014 1,977,670 Changes in goodwill during the year - Balance as of September 30, 2015 $ 1,977,670

Lease Commitments (Tables)

Lease Commitments (Tables)	9 Months Ended
	Sep. 30, 2015
Leases, Operating [Abstract]
Schedule of Lease Commitments	Year Office Space Servers Total 2015 $ 133,269 $ 4,500 $ 137,769 2016 423,943 18,000 441,943 2017 186,516 6,000 192,516 $ 743,727 $ 28,500 $ 772,227

Obligations Under Capital Lea30

Obligations Under Capital Lease (Tables)	9 Months Ended
	Sep. 30, 2015
Leases, Capital [Abstract]
Schedule of Future Minimum Lease Payments for Capital Leases	Minimum Lease Payments Total SMI MRI SMI PACS/RIS Lease SMI Xray Lease PV,PN, PC PACS/RIS Lease PV,PN,PC Computers Lease CTS Computers Lease 2015 $ 60,255 33,038 9,345 4,486 9,308 2,439 1,639 2016 240,916 132,152 37,380 17,944 37,128 9,758 6,554 2017 107,951 - 37,380 17,944 37,128 8,945 6,554 2018 93,545 - 37,380 17,944 37,128 - 1,092 2019 83,356 - 34,265 11,963 37,128 - - 2020 3,094 - - - 3,094 - - Total minimum lease payments 589,118 165,190 155,750 70,282 160,914 21,142 15,840 Less amount representing interest 53,342 11,027 17,377 8,168 14,082 2,250 437 Present value of minimum lease payments 535,776 154,163 138,373 62,114 146,832 18,892 15,403 Less current portion of minimum lease payments 212,427 121,695 30,288 14,432 31,541 8,199 6,272 Long-term capital lease obligations $ 323,349 32,468 108,085 47,682 115,291 10,693 9,131

Convertible Notes (Tables)

Convertible Notes (Tables)	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt	Series B Issuance December 31, December 31, Nine Months Nine Months Nine Months September 30, Maturity Date 2014 2014 Ended Ended Ended 2015 Date Balance Unamortized September 30, September 30, September 30, Balance, net Discount 2015 2015 2015 Beginning Interest (Payments) Amortization Balance Accrued of Debt Discount 03-Dec-12 $ 25,000 $ (344) $ 2,250 $ (2,250) $ 281 $ 24,937 31-Dec-15 03-Dec-12 125,000 (5,594) 11,250 (11,250) 3,731 123,137 31-Dec-15 03-Dec-12 50,000 (1,031) 4,500 (4,500) 844 49,813 31-Dec-15 03-Dec-12 25,000 (344) 2,250 (2,250) 281 24,937 31-Dec-15 03-Dec-12 25,000 (344) 2,250 (2,250) 281 24,937 31-Dec-15 03-Dec-12 25,000 (344) 2,250 (2,250) 281 24,937 31-Dec-15 03-Dec-12 1,500,000 (61,875) 135,000 (135,000) 50,625 1,488,750 01-Jul-18 03-Dec-12 50,000 (1,031) 4,500 (4,500) 844 49,813 31-Dec-15 03-Dec-12 15,000 (206) 1,350 (1,350) 169 14,963 31-Dec-15 03-Dec-12 100,000 (3,656) 9,000 (9,000) 2,569 98,913 31-Dec-15 27-Mar-13 25,000 (646) 2,250 (2,250) 388 24,742 31-Mar-16 27-Mar-13 25,000 (646) 2,250 (2,250) 388 24,742 31-Mar-16 27-Mar-13 25,000 (646) 2,250 (2,250) 388 24,742 31-Mar-16 Total $ 2,015,000 $ (76,706) $ 181,350 $ (181,350) $ 61,068 $ 1,999,362 Series C Issuance December 31, Unamortized Nine Months Nine Months Nine Months Nine Months September 30, Maturity Date 2014 Discount Ended Ended Ended Ended 2015 Date Balance Beginning September 30, September 30, September 30, September 30, Balance, net Balance 2015 2015 2015 2015 Proceeds Interest (Payments) Amortization Accrued of Debt Discount 22-May-14 $ 50,000 $ (2,417) $ - $ 4,500 $ (4,500) $ 750 $ 48,333 31-May-17 22-May-14 22,500 (1,088) - 2,025 (2,025) 338 21,750 31-May-17 22-May-14 22,500 (1,088) - 2,025 (2,025) 338 21,750 31-May-17 25-Aug-14 50,000 (3,419) - 4,500 (4,500) 993 47,574 31-October-17 25-Aug-14 25,000 (1,709) - 2,250 (2,250) 496 23,787 31-October-17 31-Oct-14 50,000 (2,479) - 4,500 (4,500) 656 48,177 31-October-17 17-Feb-15 - (1,040) 20,000 1,400 (1,400) 202 19,162 17-February-18 Total $ 220,000 $ (13,240) $ 20,000 $ 21,200 $ (21,200) $ 3,772 $ 230,532
Schedule of Long-term Debt Instruments	September 30, 2015 December 31, 2014 Convertible note Beginning Balance $ 260,000 $ 300,000 Less: unamortized debt discount (12,750) (19,125) Convertible notes principal, net 247,250 280,875 Less: Payments in Period (66,533) (66,504) Added: Accrued interest 21,533 26,504 Total Convertible note, net $ 202,250 $ 240,875 Less: short term portion, net 56,442 54,263 Long term portion, net $ 145,808 $ 186,612
Schedule of Maturities of Long-term Debt	Series B Principal Payments Interest Payments Amortization of Discount 2015 $ 365,000 $ 60,450 $ 14,088 2016 150,000 184,500 1,550 2017 - 180,000 - 2018 1,500,000 90,000 Total $ 2,015,000 $ 514,950 $ 15,638 Series C Principal Payments Interest Payments Amortization of Discount 2015 $ - $ 7,200 $ 1,105 2016 - 24,400 4,876 2017 220,000 12,650 3,429 2018 20,000 400 58 Total $ 240,000 $ 44,650 $ 9,468 Individually Issued Convertible Notes Principal Payments Interest Payments Amortization of Discount 2015 $ 15,000 $ 6,352 $ 2,125 2016 60,000 20,748 8,500 2017 140,000 2,625 2,125 Total $ 215,000 $ 29,725 $ 12,750

Promissory Notes (Tables)

Promissory Notes (Tables)	9 Months Ended
	Sep. 30, 2015
Other Liabilities Disclosure [Abstract]
Schedule of Promissory Notes	Promissory notes at January 1, 2014 $ 45,015 Added: Note assigned through December 31, 2014 64,937 Added: Accrued Interest through December 31, 2014 6,069 Added: Proceeds through December 31, 2014 50,000 Less: Payments through December 31, 2014 (31,022) Promissory notes at December 31, 2014 $ 134,999 Added: Accrued Interest through September 30, 2015 2,000 Added: Proceeds through September 30, 2015 1,425,835 Less: Payments through September 30, 2015 (1,004,973) Added: Discount through September 30, 2015 (129,917) Promissory notes at September 30, 2015 $ 427,944 Less: Short term portion 427,944 Long term portion September 30, 2015 $ -

Major Customers (Tables)

Major Customers (Tables)	9 Months Ended
	Sep. 30, 2015
Major Customers
Schedule of Revenue by Major Customers	Nine Months Ended Nine Months Ended September 30, 2015 September 30, 2014 Customers Revenue amount Revenue percentage Revenue amount Revenue percentage Contract A $ - 0% $ 650,079 17% Contract E 436,666 12% 698,618 18% Contract F 262,019 7% 430,57 11%

Organization and Summary of S34

Organization and Summary of Significant Accounting Policies - Basic and Diluted Earners Per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Numerator
Total comprehensive loss	$ (497,978)	$ (15,777)	$ (840,688)	$ (65,323)
Denominator
Weighted average number of shares outstanding - basic and diluted	24,166,481	23,850,828	24,143,183	23,688,366
Earnings per Share
Basic earnings per share from total comprehensive income (loss)	$ (0.021)	$ (0.001)	$ (0.035)	$ (0.003)
Diluted earnings per share from total comprehensive income (loss)	$ (0.021)	$ (0.001)	$ (0.035)	$ (0.003)

Organization and Summary of S35

Organization and Summary of Significant Accounting Policies - PPE Amortization and Depreciation (Details Narrative)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Equipment
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	3 - 7 years
Furniture and Fixtures
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	5 - 7 years
Non-compete Contract
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	3 - 5 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	39 years	39 years

Organization and Summary of S36

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Accounts Receivable, Net, Current
Allowance for bad debts	$ 70,203		$ 70,203		$ 64,673
Bad debt expense (recapture)	(849)	$ (515)	$ 5,530	$ 14,465
Accounts receivable, concentration risk			9.00%		16.00%
Goodwill and Indefinite Intangible Assets
Goodwill	1,977,670		$ 1,977,670		$ 1,977,670	$ 1,422,670
Recognized Share-Based Compensation Expense
Stock-based compensation expense, non-employees			34,683	0
Stock-based compensation expense, employees	0	0	58,236	150
Stock options granted to employees			47,896
Labor and management fees			34,683	13,213
Other Income and (Expenses):
Foreign currency gains (losses)	14,046	145	(3,473)	954
Other comprehensive income (loss)	28,633	$ 334	85,684	$ 63
Contract-Based Intangible Assets | SMI
Goodwill and Indefinite Intangible Assets
Goodwill	1,422,670		1,422,670
Contract-Based Intangible Assets | PIC
Goodwill and Indefinite Intangible Assets
Goodwill	132,143		132,143
Contract-Based Intangible Assets | PIN
Goodwill and Indefinite Intangible Assets
Goodwill	158,571		158,571
Contract-Based Intangible Assets | PIV
Goodwill and Indefinite Intangible Assets
Goodwill	$ 264,286		$ 264,286

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,458,377	$ 3,402,671
Property and equipment, accumulated depreciation	864,694	463,977
Property and equipment, net	2,593,683	2,938,694
Computer/Office Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 457,776	$ 435,867
Property and equipment, estimated useful lives	3-7 years	3-7 years
Medical Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,156,820	$ 2,123,023
Property and equipment, estimated useful lives	3-7 years	3-7 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 843,781	$ 843,781
Property and equipment, estimated useful lives	39 years	39 years

Property and Equipment (Detai38

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Depreciation expense	$ 137,116	$ 50,252	$ 409,854	$ 129,907
Computer/Office Equipment | CTS
Payments to acquire equipment			30,834
Medical Equipment
Payments to acquire equipment			$ 33,796

Business Combination - Consider

Business Combination - Consideration Transfered (Details)	12 Months Ended
	Dec. 31, 2014USD ($)
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	$ 1,800,000
Total consideration paid	1,800,000
PIV
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	959,286
Total consideration paid	959,286
PIN
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	533,571
Total consideration paid	533,571
PIC
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	307,143
Total consideration paid	$ 307,143

Business Combination - Recogniz

Business Combination - Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)	Dec. 31, 2014USD ($)
Business Acquisition [Line Items]
Fair value fixed assets	$ 1,245,000
Fair value goodwill	555,000
Fair value net assets purchased	1,800,000
PIV
Business Acquisition [Line Items]
Fair value fixed assets	695,000
Fair value goodwill	264,286
Fair value net assets purchased	959,286
PIN
Business Acquisition [Line Items]
Fair value fixed assets	375,000
Fair value goodwill	158,571
Fair value net assets purchased	533,571
PIC
Business Acquisition [Line Items]
Fair value fixed assets	175,000
Fair value goodwill	132,143
Fair value net assets purchased	$ 307,143

Business Combination - Revenue

Business Combination - Revenue and Gross Earnings (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Business Acquisition [Line Items]
Revenue from business combination	$ 2,282,359	$ 0
Gross Earnings from business combination	1,329,854	0
PIV
Business Acquisition [Line Items]
Revenue from business combination	1,064,262	0
Gross Earnings from business combination	591,889	0
PIN
Business Acquisition [Line Items]
Revenue from business combination	555,754	0
Gross Earnings from business combination	328,564	0
PIC
Business Acquisition [Line Items]
Revenue from business combination	662,343	0
Gross Earnings from business combination	$ 409,401	$ 0

Business Combination (Details N

Business Combination (Details Narrative)	12 Months Ended
	Dec. 31, 2014USD ($)
Business Combinations [Abstract]
Share Purchase Agreement, purchase price	$ 1,800,000
Business combination, costs related to the acquisition	29,500
Business combination, goodwill	$ 555,000

Goodwill (Details)

Goodwill (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Goodwill [Roll Forward]
Goodwill, balance at beginning of period	$ 1,977,670	$ 1,422,670
Changes in Goodwill	0	0
Goodwill, Acquired During Period	0	555,000
Goodwill, balance at end of period	$ 1,977,670	$ 1,977,670

Lease Commitments (Details)

Lease Commitments (Details)	Sep. 30, 2015USD ($)
Operating Leased Assets [Line Items]
Year 2,015	$ 137,769
Year 2,016	441,943
Year 2,017	192,516
Operating Leases, Future Minimum Payments Due	772,227
Office Space
Operating Leased Assets [Line Items]
Year 2,015	133,269
Year 2,016	423,943
Year 2,017	186,516
Operating Leases, Future Minimum Payments Due	743,727
Computer/Office Equipment
Operating Leased Assets [Line Items]
Year 2,015	4,500
Year 2,016	18,000
Year 2,017	6,000
Operating Leases, Future Minimum Payments Due	$ 28,500

Lease Commitments (Details Narr

Lease Commitments (Details Narrative)	9 Months Ended
	Sep. 30, 2015USD ($)
CTS - Office Space
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 6,000
Leasing arrangements	CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $3,550 in utilities, realty taxes, and operating costs. The Lease renewed in April 2013 for a period of five years and will expire in March 2018.
Rental credit	$ 28,000
SMI - Office Space - Pottsville, Pennsylvania
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 7,111
Leasing arrangements	SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions.
SMI - Office Space - Dallas, Texas
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 880
Leasing arrangements	SMI has a lease for office space that will expire in August 31, 2016.
PIV
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 15,377
Leasing arrangements	PIV has a lease for office space in Venice, Florida. The lease will expire October 1, 2016.
PIN
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 9,543
Leasing arrangements	PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020.
PIC
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 5,512
Leasing arrangements	PIC has a lease for office space in Port Charlotte, Florida. The lease will expire June 20, 2016.

Accounts Payable and Accrued 46

Accounts Payable and Accrued Liabilities (Details Narrative) - USD ($)	Sep. 30, 2015		Dec. 31, 2014
Payables and Accruals [Abstract]
Trade payables and accrued expenses	$ 1,533,403		$ 935,688
Trade payables	$ 1,069,240	[1]	$ 624,141	[2]
[1]	Includes $288,502 was related to accrued payroll and withholdings liabilities, and $175,661 was related to Federal and State income tax owing.
[2]	Includes $73,461 was related to accrued payroll and withholdings liabilities, and $238,086 was related to Federal and State income tax owing.

Obligations Under Capital Lea47

Obligations Under Capital Lease (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	$ 60,255
Minimum future lease payments, 2016	240,916
Minimum future lease payments, 2017	107,951
Minimum future lease payments, 2018	93,545
Minimum future lease payments, 2019	83,356
Minimum future lease payments, 2020	3,094
Total minimum lease payments	589,118
Less amount representing interest	53,342
Present value of minimum lease payments	535,776
Less current portion of minimum lease payments	212,427
Obligations Under Capital Lease, long term portion	323,366	$ 459,853
SMI - MRI
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	33,038
Minimum future lease payments, 2016	132,152
Minimum future lease payments, 2017	0
Minimum future lease payments, 2018	0
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	165,190
Less amount representing interest	11,027
Present value of minimum lease payments	154,163
Less current portion of minimum lease payments	121,695
Obligations Under Capital Lease, long term portion	32,468
SMI - PACS/RIS Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	9,345
Minimum future lease payments, 2016	37,380
Minimum future lease payments, 2017	37,380
Minimum future lease payments, 2018	37,380
Minimum future lease payments, 2019	34,265
Minimum future lease payments, 2020	0
Total minimum lease payments	155,750
Less amount representing interest	17,377
Present value of minimum lease payments	138,373
Less current portion of minimum lease payments	30,288
Obligations Under Capital Lease, long term portion	108,085
SMI - Xray Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	4,486
Minimum future lease payments, 2016	17,944
Minimum future lease payments, 2017	17,944
Minimum future lease payments, 2018	17,944
Minimum future lease payments, 2019	11,963
Minimum future lease payments, 2020	0
Total minimum lease payments	70,282
Less amount representing interest	8,168
Present value of minimum lease payments	62,114
Less current portion of minimum lease payments	14,432
Obligations Under Capital Lease, long term portion	47,682
PV, PN, PC PACS/RIS Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	9,308
Minimum future lease payments, 2016	37,128
Minimum future lease payments, 2017	37,128
Minimum future lease payments, 2018	37,128
Minimum future lease payments, 2019	37,128
Minimum future lease payments, 2020	3,094
Total minimum lease payments	160,914
Less amount representing interest	14,082
Present value of minimum lease payments	146,832
Less current portion of minimum lease payments	31,541
Obligations Under Capital Lease, long term portion	115,291
PV, PN, PC Computers Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	2,439
Minimum future lease payments, 2016	9,758
Minimum future lease payments, 2017	8,945
Minimum future lease payments, 2018	0
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	21,142
Less amount representing interest	2,250
Present value of minimum lease payments	18,892
Less current portion of minimum lease payments	8,199
Obligations Under Capital Lease, long term portion	10,693
CTS Computers Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	1,639
Minimum future lease payments, 2016	6,554
Minimum future lease payments, 2017	6,554
Minimum future lease payments, 2018	1,092
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	15,840
Less amount representing interest	437
Present value of minimum lease payments	15,403
Less current portion of minimum lease payments	6,272
Obligations Under Capital Lease, long term portion	$ 9,131

Obligations Under Capital Lea48

Obligations Under Capital Lease (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
SMI - MRI
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$ 555,000		$ 555,000
Capital leases, equipment, net	240,583		240,583
Capital leases, depreciation expense	27,750	$ 27,750	83,250	$ 83,250
Capital leases, accumulated amortization	314,417		$ 314,417
Capital leases, leasing arrangements			On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
SMI - PACS/RIS Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	162,333		$ 162,333
Capital leases, equipment, net	116,133		116,133
Capital leases, depreciation expense	8,117	4,058	24,350	4,058
Capital leases, accumulated amortization	46,200		$ 46,200
Capital leases, leasing arrangements			On August 19, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $3,115, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the system for a total purchase price of $1.00.
SMI - Xray Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	78,250		$ 78,250
Capital leases, equipment, net	58,688		58,688
Capital leases, depreciation expense	3,913	39,313	11,738	3,913
Capital leases, accumulated amortization	19,562		$ 19,562
Capital leases, leasing arrangements			On July 03, 2014 Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.
PV, PN, PC PACS/RIS Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	167,107		$ 167,107
Capital leases, equipment, net	140,648		140,648
Capital leases, depreciation expense	8,355	0	25,065	0
Capital leases, accumulated amortization	26,459		$ 26,459
Capital leases, leasing arrangements			On November 26, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, PIV, is to make monthly payments of $3,094, plus applicable sales tax, over a period of 60 months. At the end of the lease, PIV will have the option to purchase the system for a total purchase price of $1.00.
PV, PN, PC Computers Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	25,108		$ 25,108
Capital leases, equipment, net	20,575		20,575
Capital leases, depreciation expense	2,092	0	6,277	0
Capital leases, accumulated amortization	6,625		$ 6,625
Capital leases, leasing arrangements			On December 10, 2014 Company has entered into a capital lease agreement to lease computers that were delivered and installed in December 2014. Under the terms of the lease, the Company is to make monthly payments of $813.16, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00.
CTS Computers Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	18,997		$ 18,997
Capital leases, equipment, net	14,776		14,776
Capital leases, depreciation expense	1,683	$ 0	4,488	$ 0
Capital leases, accumulated amortization	$ 4,221		$ 4,221
Capital leases, leasing arrangements			On January 21, 2015 the company has entered into a capital lease agreement to lease computers that were installed on the same date of acceptance. Under the terms of the lease, the company is to make monthly payments of $546, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00.

Convertible Notes - Details of

Convertible Notes - Details of Series B and C Notes (Details) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Convertible note, maturity date	Jul. 7, 2016	Apr. 5, 2016	Feb. 1, 2015
Series B - Note 1
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 25,000
Convertible note, accrued interest		2,250
Convertible note, payments		(2,250)
Convertible note, amortization of debt discount		281
Convertible note, unamortized debt discount		(344)
Convertible note, ending balance	$ 24,937	$ 24,937	$ 25,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 2
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 125,000
Convertible note, accrued interest		11,250
Convertible note, payments		(11,250)
Convertible note, amortization of debt discount		3,731
Convertible note, unamortized debt discount		(5,594)
Convertible note, ending balance	123,137	$ 123,137	125,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 3
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 50,000
Convertible note, accrued interest		4,500
Convertible note, payments		(4,500)
Convertible note, amortization of debt discount		844
Convertible note, unamortized debt discount		(1,031)
Convertible note, ending balance	49,813	$ 49,813	50,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 4
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 25,000
Convertible note, accrued interest		2,250
Convertible note, payments		(2,250)
Convertible note, amortization of debt discount		281
Convertible note, unamortized debt discount		(344)
Convertible note, ending balance	24,937	$ 24,937	25,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 5
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 25,000
Convertible note, accrued interest		2,250
Convertible note, payments		(2,500)
Convertible note, amortization of debt discount		281
Convertible note, unamortized debt discount		(344)
Convertible note, ending balance	24,937	$ 24,937	25,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 6
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 25,000
Convertible note, accrued interest		2,250
Convertible note, payments		(2,250)
Convertible note, amortization of debt discount		281
Convertible note, unamortized debt discount		(344)
Convertible note, ending balance	24,937	$ 24,937	25,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 7
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 1,500,000
Convertible note, accrued interest		135,000
Convertible note, payments		(135,000)
Convertible note, amortization of debt discount		50,625
Convertible note, unamortized debt discount		(61,875)
Convertible note, ending balance	1,488,750	$ 1,488,750	1,500,000
Convertible note, maturity date		Jul. 1, 2018
Series B - Note 8
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 50,000
Convertible note, accrued interest		4,500
Convertible note, payments		(4,500)
Convertible note, amortization of debt discount		844
Convertible note, unamortized debt discount		(1,031)
Convertible note, ending balance	49,813	$ 49,813	50,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 9
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 15,000
Convertible note, accrued interest		1,350
Convertible note, payments		(1,350)
Convertible note, amortization of debt discount		169
Convertible note, unamortized debt discount		(206)
Convertible note, ending balance	14,963	$ 14,963	15,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 10
Debt Instrument [Line Items]
Convertible note, issuance date		Dec. 3, 2012
Convertible note, beginning balance		$ 100,000
Convertible note, accrued interest		9,000
Convertible note, payments		(9,000)
Convertible note, amortization of debt discount		2,569
Convertible note, unamortized debt discount		(3,656)
Convertible note, ending balance	98,913	$ 98,913	100,000
Convertible note, maturity date		Dec. 31, 2015
Series B - Note 11
Debt Instrument [Line Items]
Convertible note, issuance date		Mar. 27, 2013
Convertible note, beginning balance		$ 25,000
Convertible note, accrued interest		2,250
Convertible note, payments		(2,250)
Convertible note, amortization of debt discount		388
Convertible note, unamortized debt discount		(646)
Convertible note, ending balance	24,742	$ 24,742	25,000
Convertible note, maturity date		Mar. 31, 2016
Series B - Note 12
Debt Instrument [Line Items]
Convertible note, issuance date		Mar. 27, 2013
Convertible note, beginning balance		$ 25,000
Convertible note, accrued interest		2,250
Convertible note, payments		(2,250)
Convertible note, amortization of debt discount		388
Convertible note, unamortized debt discount		(646)
Convertible note, ending balance	24,742	$ 24,742	25,000
Convertible note, maturity date		Mar. 31, 2016
Series B - Note 13
Debt Instrument [Line Items]
Convertible note, issuance date		Mar. 27, 2013
Convertible note, beginning balance		$ 25,000
Convertible note, accrued interest		2,250
Convertible note, payments		(2,250)
Convertible note, amortization of debt discount		388
Convertible note, unamortized debt discount		(646)
Convertible note, ending balance	24,742	$ 24,742	25,000
Convertible note, maturity date		Mar. 31, 2016
Series C - Note 1
Debt Instrument [Line Items]
Convertible note, issuance date		May 22, 2014
Convertible note, beginning balance		$ 50,000
Convertible note, accrued interest		4,500
Convertible note, payments		(4,500)
Convertible note, amortization of debt discount		750
Convertible note, unamortized debt discount		(2,417)
Convertible note, ending balance	48,333	$ 48,333	50,000
Convertible note, maturity date		May 31, 2017
Series C - Note 2
Debt Instrument [Line Items]
Convertible note, issuance date		May 22, 2014
Convertible note, beginning balance		$ 22,500
Convertible note, accrued interest		2,025
Convertible note, payments		(2,025)
Convertible note, amortization of debt discount		338
Convertible note, unamortized debt discount		(1,088)
Convertible note, ending balance	21,750	$ 21,750	22,500
Convertible note, maturity date		May 31, 2017
Series C - Note 3
Debt Instrument [Line Items]
Convertible note, issuance date		May 22, 2014
Convertible note, beginning balance		$ 22,500
Convertible note, accrued interest		2,025
Convertible note, payments		(2,025)
Convertible note, amortization of debt discount		338
Convertible note, unamortized debt discount		(1,088)
Convertible note, ending balance	21,750	$ 21,750	22,500
Convertible note, maturity date		May 31, 2017
Series C - Note 4
Debt Instrument [Line Items]
Convertible note, issuance date		Aug. 25, 2014
Convertible note, beginning balance		$ 50,000
Convertible note, accrued interest		4,500
Convertible note, payments		(4,500)
Convertible note, amortization of debt discount		993
Convertible note, unamortized debt discount		(3,419)
Convertible note, ending balance	47,574	$ 47,574	50,000
Convertible note, maturity date		Oct. 31, 2017
Series C - Note 5
Debt Instrument [Line Items]
Convertible note, issuance date		Aug. 25, 2014
Convertible note, beginning balance		$ 25,000
Convertible note, accrued interest		2,250
Convertible note, payments		(2,250)
Convertible note, amortization of debt discount		496
Convertible note, unamortized debt discount		(1,709)
Convertible note, ending balance	23,787	$ 23,787	25,000
Convertible note, maturity date		Oct. 31, 2017
Series C - Note 6
Debt Instrument [Line Items]
Convertible note, issuance date		Oct. 31, 2014
Convertible note, beginning balance		$ 50,000
Convertible note, accrued interest		4,500
Convertible note, payments		(4,500)
Convertible note, amortization of debt discount		656
Convertible note, unamortized debt discount		(2,479)
Convertible note, ending balance	48,177	$ 48,177	50,000
Convertible note, maturity date		Oct. 31, 2017
Series C - Note 7
Debt Instrument [Line Items]
Convertible note, issuance date		Feb. 17, 2015
Convertible note, beginning balance		$ 0
Convertible note, proceeds		20,000
Convertible note, accrued interest		1,400
Convertible note, payments		(1,400)
Convertible note, amortization of debt discount		202
Convertible note, unamortized debt discount		(1,040)
Convertible note, ending balance	$ 19,162	$ 19,162	$ 0
Convertible note, maturity date		Feb. 17, 2018

Convertible Notes - Summary of

Convertible Notes - Summary of Individually Issued Notes (Details) - Convertible Notes - Individually Issued - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Convertible notes	$ 260,000	$ 300,000
Less: unamortized debt discount	(12,750)	(19,125)
Convertible notes principal, net	247,250	280,875
Less: Payment in period	(66,533)	(66,504)
Added: Accrued interest	21,533	26,504
Total convertible notes, net	202,250	240,875
Less: Short term portion, net	56,442	54,263
Long term portion, net	$ 145,808	$ 186,612

Convertible Notes - Long-Term D

Convertible Notes - Long-Term Debt Maturities (Details) - Convertible Notes	9 Months Ended
	Sep. 30, 2015USD ($)
Individually Issued
Debt Instrument [Line Items]
Principal payments, 2015	$ 15,000
Principal payments, 2016	60,000
Principal payments, 2017	140,000
Interest payments, 2015	6,352
Interest payments, 2016	20,748
Interest payments, 2017	2,625
Amortization expense, 2015	2,125
Amortization expense, 2016	8,500
Amortization expense, 2017	2,125
Series C Notes
Debt Instrument [Line Items]
Principal payments, 2017	220,000
Principal payments, 2018	20,000
Interest payments, 2015	7,200
Interest payments, 2016	24,400
Interest payments, 2017	12,650
Interest payments, 2018	400
Amortization expense, 2015	1,105
Amortization expense, 2016	4,876
Amortization expense, 2017	3,429
Amortization expense, 2018	58
Series B Notes
Debt Instrument [Line Items]
Principal payments, 2015	365,000
Principal payments, 2016	150,000
Principal payments, 2018	1,500,000
Interest payments, 2015	60,450
Interest payments, 2016	184,500
Interest payments, 2017	180,000
Interest payments, 2018	90,000
Amortization expense, 2015	14,088
Amortization expense, 2016	$ 1,550

Convertible Notes (Details Narr

Convertible Notes (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Convertible notes, payment terms	The loan terms call for a daily payment of $1,066, towards the principal balance and interest.	The loan terms call for weekly payments of $41,000 towards the principal balance and interest.
Convertible notes, interest rate			12.00%
Convertible Notes | Individually Issued
Debt Instrument [Line Items]
Convertible notes, sold			$ 300,000
Convertible notes, payment terms			The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. The Company will also be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for 3 years until the note due date of February 27, 2017.
Convertible notes, price per share for conversion of shares of common stock			$ 0.15
Convertible notes, interest rate			12.00%
Note holder additions			The non-affiliate will receive 300,000 shares as part of the note agreement.
Additional paid in capital and discount		$ 25,500
Amortization of debt discount		6,375
Convertible note, accrued interest		21,533
Private placement, maturity date			Feb. 27, 2017
Common stock issued			300,000
Convertible Notes | Series C Notes
Debt Instrument [Line Items]
Convertible notes, sold		20,000	$ 125,000
Convertible notes, payment terms			Series C Notes bear interest at a rate of 12% per annum, payable to the holder at 1% per month, with principal amount due May 31, 2017.
Convertible notes, price per share for conversion of shares of common stock			$ 0.15
Convertible notes, interest rate			12.00%
Additional paid in capital and discount		12,695
Amortization of debt discount		3,772
Convertible note, accrued interest		$ 21,200
Private placement, 12% convertible notes, principal amount			$ 95,000
Private placement, maturity date			May 31, 2017
Common stock issued	240,000	240,000
Convertible Notes | Series B Notes
Debt Instrument [Line Items]
Convertible notes, sold				$ 150,000
Convertible notes, payment terms				Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month.
Convertible notes, price per share for conversion of shares of common stock				$ 0.10
Convertible notes, interest rate				12.00%
Additional paid in capital and discount		$ 244,275
Amortization of debt discount		61,068
Convertible note, accrued interest		$ 181,350
Private placement, 12% convertible notes, principal amount				$ 1,865,000
Private placement, maturity date, description				Series B Notes issued December 3, 2012 for $1,865,000 mature on July 1, 2018 and Series B Notes issued March 27, 2013 for $150,000 mature on March 31, 2016.
Common stock issued				5,315,000

Promissory Notes (Details)

Promissory Notes (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Promissory notes, beginning of period	$ 134,999	$ 45,015
Proceeds from notes issuances	1,425,835	50,000
Promissory note assigned		64,937
Accrued interest	2,000	6,069
Payments through end of period	(1,004,973)	(31,022)
Amortization of debt discount	(129,917)
Promissory notes, end of period	427,944	$ 134,999
Promissory notes, short-term portion	427,944
Promissory notes, long-term portion	$ 0

Promissory Notes (Details Narra

Promissory Notes (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2015	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Promissory note, payments through end of period		$ 54,000
Promissory note, additional proceeds		$ 4,000	$ 50,000
Promissory note, assigned			$ (64,937)
Promissory note, interest rate			12.00%
Promissory note, maturity date	Jul. 7, 2016	Apr. 5, 2016	Feb. 1, 2015
Short term loan payable issued	$ 284,062	$ 1,149,000
Short term loan payable, repayment terms	The loan terms call for a daily payment of $1,066, towards the principal balance and interest.	The loan terms call for weekly payments of $41,000 towards the principal balance and interest.

Royalty Financing (Details Narr

Royalty Financing (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Royalty Financing
Royalty purchase agreement			On October 31, 2014, the Company entered into a royalty purchase agreement with Grenville Strategic Royalty Corp. for the amount of $2,000,000. The agreement calls for a monthly payment to the seller based on a percentage of the total of certain revenue items and subject to a minimum payment amount.
Royalty payments	$ 310,348	$ 0
Discounted amortization expense	307,056
Accrued royalties	$ 1,960,679

Major Customers (Details)

Major Customers (Details) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Revenue, Major Customer [Line Items]
Major customer percent of revenue	9.00%		16.00%
Customer Concentration Risk | Contract F
Revenue, Major Customer [Line Items]
Major customer revenues	$ 262,019	$ 430,570
Major customer percent of revenue	7.00%	11.00%
Customer Concentration Risk | Contract E
Revenue, Major Customer [Line Items]
Major customer revenues	$ 436,666	$ 698,618
Major customer percent of revenue	12.00%	18.00%
Customer Concentration Risk | Contract A
Revenue, Major Customer [Line Items]
Major customer revenues	$ 0	$ 650,079
Major customer percent of revenue	0.00%	17.00%

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - Major Shareholder	9 Months Ended
	Sep. 30, 2015$ / sharesshares
Consulting services, description	January 2015, the Company entered into an agreement with a company that is owned and controlled by a major shareholder, to provide consulting services. Fees payable for performance of the consulting services are $10,000 per month.
Stock options, granted | shares	4,200,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months

Common Stock Transactions (Deta

Common Stock Transactions (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Convertible Notes | Individually Issued
Shares issued, convertible notes, shares		300,000
Shares issued, convertible notes, value		$ 25,500
Convertible Notes | Series C Notes
Shares issued, convertible notes, shares	20,000	220,000
Shares issued, convertible notes, value	$ 1,040	$ 14,280
Common Stock
Shares issued for services, shares	200,000	5,000
Shares issued for services, value	$ 10,340	$ 150
Major Shareholder
Stock options, granted	4,200,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 34,683
Chief Executive Officer
Stock options, granted	4,200,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 34,683
Chief Financial Officer
Stock options, granted	1,600,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 13,213

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Going Concern
Net Loss	$ (526,611)	$ (16,111)	$ (926,372)	$ (65,386)
Working capital deficit	$ 1,401,076		$ 1,401,076

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	1 Months Ended
	Nov. 13, 2015
Subsequent Event | Convertible Notes | Series B Notes
Subsequent Event [Line Items]
Convertible debt extension	A non-related party holder of $1,500,000 of series B convertible has agreed to extend the maturity date to July 1, 2017. As consideration for this extension, the company will issue to the holder a warrant to purchase 1,500,000 shares of common stock of the company at an exercise price of $0.07 per share, which warrant will be exercisable from November 16, 2015 to and including July 1, 2018.